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BACKGROUND: There is increasing evidence that environmental, rather than genetic, factors are the major causes of most chronic diseases. By meas-
uring entire classes of chemicals in archived biospecimens, exposome-wide association studies (EWAS) are being conducted to investigate associa-
tions between a myriad of exposures received during life and chronic diseases.
OBJECTIVES: Because the intraindividual variability in biomarker levels, arising from changes in environmental exposures from conception onwards,
leads to attenuation of exposure–disease associations, we posit that saliva can be collected repeatedly in longitudinal studies to reduce exposure–mea-
surement errors in EWAS.
METHODS: From the literature and an open-source saliva–metabolome database, we obtained concentrations of 1,233 chemicals that had been detected
in saliva. We connected salivary metabolites with human metabolic pathways and PubMed Medical Subject Heading (MeSH) terms, and performed
pathway enrichment and pathway topology analyses.
RESULTS: One hundred ninety-six salivary metabolites were mapped into 49 metabolic pathways and connected with human metabolic diseases, cen-
tral nervous system diseases, and neoplasms. We found that the saliva exposome represents at least 14 metabolic pathways, including amino acid me-
tabolism, TCA cycle, gluconeogenesis, glutathione metabolism, pantothenate and CoA biosynthesis, and butanoate metabolism.
CONCLUSIONS: Saliva contains molecular information worthy of interrogation via EWAS. The simplicity of specimen collection suggests that saliva
offers a practical alternative to blood for measurements that can be used to characterize individual exposomes. https://doi.org/10.1289/EHP1011
Introduction
Because genetic factors typically account for only about 18% of
chronic disease risks, it is reasonable to infer that nongenetic fac-
tors (i.e., exposures) are major causes of chronic diseases
(Rappaport 2016). Given the myriad exposures from both exoge-
nous and endogenous sources that an individual experiences dur-
ing life [the “exposome” (Wild 2005)], investigators are
performing exposome-wide association studies (EWAS) that in-
terrogate levels of chemicals in biospecimens to discover causes
of chronic diseases (Patel et al. 2010; Rappaport 2012; Wild
et al. 2013). By measuring entire classes of chemicals (e.g., small
molecules, protein modifications, antigens) in archived biospeci-
mens from incident disease cases and matched controls, EWAS
can pinpoint discriminating features that then generate hypothe-
ses for targeted follow-up studies (Rappaport 2011; Rappaport
et al. 2014). For example, Hazen and coworkers employed this
avenue to implicate joint microbial/human metabolism of the nu-
trient choline as a potentially major cause of coronary heart dis-
ease (Wang et al. 2011; Tang et al. 2013; Koeth et al. 2013).
An important challenge to designing EWAS is the intraindi-
vidual variability in levels of circulating molecules arising from
changes in diet, lifestyle factors, and sources of pollutants during
decades of life that precede disease onset. This within-person var-
iability in biomarker levels leads to exposure measurement errors
that attenuate causal signals and obscure disease associations
(Lin et al. 2005; Sampson et al. 2013). One way to circumvent
such measurement errors is to perform longitudinal studies with
repeated biospecimens, collected from subjects during critical
stages of life (Rappaport 2011; Robinson and Vrijeheid 2015).
The most logical approach for doing this relies on prospective
cohorts that archived blood or other biospecimens repeatedly
from the same subjects. However, such cohorts are rare and
repeated collection of blood, the main archival specimen, is diffi-
cult to perform (Hansen et al. 2007; Randell et al. 2016).
Saliva (also referred as oral fluid) is a natural filtrate of blood
that contains omic features (small molecules, metals, proteins,
and DNA) worthy of interrogation via EWAS. Because collection
is “stress-free,” repeated specimens of saliva are routinely
obtained for determination of steroid hormones in psychobiologi-
cal studies (Hjortskov et al. 2004; Kajantie and Phillips 2006;
Hunter et al. 2011). Sampling of saliva is straightforward and
protocols are available that allow subjects to collect their own
samples and ship them to a laboratory or repository.
Metabolomics is recognized as a powerful top-down approach
for detecting small molecules in biological matrices (Nicholson
and Wilson 2003; German et al. 2005). These small molecules
can be either substrates or end products of cellular metabolism
and can originate from exogenous sources via inhalation, inges-
tion and dermal absorption, or from endogenous processes
including human and microbial metabolism. Adductomics is
another top-down technique that employs modifications of blood
proteins like hemoglobin or human serum albumin (HSA) to
characterize exposures to reactive electrophiles that are inher-
ently toxic but cannot be measured directly in biospecimens
(Rubino et al. 2009; Li et al. 2011; Carlsson et al. 2014;
Grigoryan et al. 2016). Because blood is in equilibrium with the
tissues and saliva is in equilibrium with blood, both blood and sa-
liva represent dynamic reservoirs of small molecules that are
present in the body at a given time. Given the potential utility of
saliva as a biospecimen for EWAS, we will evaluate the linkages
between salivary metabolites and human metabolic pathways, as
well as those between these pathways and chronic diseases. We
will also consider methods for collection and analysis of saliva
via untargeted metabolomics and adductomics.
Methods
Saliva Metabolome
Salivary metabolites (n=1,233) were obtained from the saliva
metabolome database (http://www.salivametabolome.ca/) that
was recently integrated into the Human Metabolome Database
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(HMDB) (Wishart et al. 2013; Dame et al. 2015). This database
compiles important physical, chemical and biological information
of metabolites derived from peer-reviewed articles, including
chemical structure, chemical class, origin, biological function,
and cellular location. Normal and abnormal concentrations are
also reported for metabolites previously quantified in humans as
well as standard deviations of the measurements that can be used
in some cases to estimate the intra- and interindividual variabili-
ty. It is important to note that this database was built from a
recent study by Dame et al. who combined contemporary meas-
urements of salivary metabolites in healthy subjects with litera-
ture data derived from the healthy and/or diseased subjects
(Dame et al. 2015). Those investigators measured 308 salivary
metabolites in 16 healthy adult subjects sampled once and two
subjects sampled three times in a day (morning, midday, and after-
noon/evening). They also reported levels of an additional 708
metabolites from peer-reviewed articles. All metabolites included
in the saliva metabolome database were used for analyses.
Visualization of Human Metabolic Pathways
Salivary metabolites were connected to their human metabolic
pathways using the Metscape 3.1 App (Karnovsky et al. 2012)
for Cytoscape 3.2.1. (Shannon et al. 2003). The network of
metabolites and reactions was built using the internal Metscape
database that integrates metabolomics and gene-expression data
derived from all available biospecimens, and compiled in the
Kyoto Encyclopedia of Genes and Genomes (KEGG) and the
Edinburgh Human Metabolic Network (EHMN) (Karnovsky
et al. 2012). Nodes (i.e., metabolites) were colored according to
their source (e.g., host, microbial). Edges connecting nodes repre-
sent KEGG and EHMN biochemical reactions. Only salivary
metabolites with a KEGG IDs (196 metabolites) were retained
with “human” as the model organism. The network type “com-
pound” was used to map metabolic connections between small
molecules.
Pathway Enrichment and Pathway Topology Analysis
Pathway enrichment and topology analyses of the saliva metabo-
lome were performed using MetaboAnalyst 3.0 (Xia et al. 2015)
with “Homo sapiens” as the model organism. Pathway enrich-
ment analysis was conducted using the hypergeometric test to
determine whether saliva metabolites were represented in a par-
ticular KEGG metabolic pathway more than expected by chance.
p-Values≤ 0:05 indicate statistically significant representations
of metabolic pathways. Pathway topology analysis was per-
formed using the “relative-betweenness” centrality measure to
estimate the importance of saliva metabolites relative to the bio-
logical pathway structure. Metabolite centrality is reported on a
scale from 0 (isolated metabolite) to 1 (key metabolite).
Connections between the Saliva Metabolome and Human
Chronic Diseases
Salivary metabolites were connected with human chronic dis-
eases using the MetDisease App for Cytoscape 3.2.1 (Duren et al.
2014). MetDisease is a text-mining App that queried metabolites
previously reported in any biospecimen as associated with
PubMed Medical Subject Heading (MeSH) terms in peer-
reviewed human and/or animal studies. For each disease, the total
number of salivary metabolites, associated with a particular
MeSH term, was determined. Salivary metabolites were queried
using their KEGG IDs as identifiers and their shared names as
select attributes. MeSH terms related to both chronic and non-
chronic diseases (e.g., bacterial infections)were included in the net-
work. The network of MeSH terms was built with Cytoscape 3.2.1
(Shannon et al. 2003) using the organic layer. The number of sali-
varymetabolites associatedwithMeSH termswas used as the node




Saliva is a mixture of fluids originating mainly from the parotid,
submandibular, sublingual, and minor salivary glands, and to a
lesser extent from oral and nasal mucosa (de Almeida et al.
2008). Saliva consists of approximately 99% water with the
remaining 1% comprised of electrolytes, mucus, cellular debris,
proteins, and small molecules (Humphrey and Williamson 2001;
de Almeida et al. 2008). Transfer of small molecules from blood
to saliva relies on passive diffusion of lipophilic compounds and
ultrafiltration of hydrophilic compounds of low molecular weight
(<300–1,900Da) (Gallardo and Queiroz 2008; de Almeida et al.
2008; Thieme 2012; Higashi 2012). The pKa of a molecule plays
an important role in transfer from blood to saliva. For example,
basic molecules accumulate in saliva due to ion-trapping phe-
nomena associated with their transfer from neutral blood
(pH 7.4) to acidic saliva (pH 6) (Thieme 2012). Also, several fac-
tors including disease states, diet, drug consumption, and physi-
cal activity can significantly affect saliva excretion and saliva pH
can be influenced by variation in bicarbonate concentrations (Aps
and Martens, 2005).
Several studies have evaluated the correlation between sa-
liva and blood concentrations for compounds with diverse phys-
ical and chemical properties, as summarized in Table 1. The
median value of the Pearson correlation coefficients was 0.92
with a range of 0:30≤ r≤ 0:98). High correlations were ob-
served between blood and saliva concentrations for neutral mol-
ecules that are not affected by changes in saliva pH (Hill et al.
2001; Sakaguchi and Hasegawa 2005; Juniarto et al. 2011;
Gunnala et al. 2015). Lower correlations for acidic and basic
compounds have been attributed to intraindividual variation in
saliva pH as well as buccal contamination (for nicotine) (Fisher
et al. 2013). However, these studies have been conducted only
on a small subset of compounds (mainly drugs and pollutants).
Because the blood–saliva transfer of small molecules relies on
physical and chemical processes, more in-depth studies are
needed to determine effects of pKa, polarity, physical activity,
diet, and disease state.
Dame et al. (2015) recently combined results from metabolo-
mic analyses of human saliva with a literature review of salivary
metabolites. This characterization of the saliva metabolome
included 1,233 small molecules, metals and ions, which is about
one-fourth of the 4,549 metabolites that have been reported in
human blood (Wishart et al. 2013). The difference in coverage of
the two metabolomes reflects the lower metabolite concentrations
observed in saliva (nM to low lM) compared with blood (lM to
mM). We classified the sources of these salivary molecules and
metals as follows: a) host endogenous (879), b) microbial endog-
enous (52), c) food (225), d) drugs (15), e) pollutants (25), and f)
metals (37) (Figure 1).
Using Metscape, we mapped the 1,233 salivary metabolites
into biological pathways (Figure 2). Metscape uses an internal
database that integrates metabolomic and gene-expression data
from KEGG and EHMN (Karnovsky et al. 2012). Because only
196 of the 1,233 (16%) metabolites detected in saliva were
included in these databases, an additional 529 metabolites were
added to the network through linkages (i.e., direct neighbor in
metabolic pathways) with the 196 salivary metabolites through
49 recognized pathways. Most of these additional 529 metabolites
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were either phase-II conjugates or compounds tightly bound to pro-
teins. In saliva, metabolites aremainly present in the free form (i.e.,
unbound fraction) due to blood-saliva transfer processes. Phase-II
conjugation increases the molecular weight, acidity, and hydrophi-
licity of each parent compound (Figure 2A), whereas protein bind-
ing increases the size of the compound. Both of these processes
limit the efficiency of blood–saliva transfer. For compounds tightly
bound to proteins, such as eicosanoids (markers of inflammation)
(Figure 2A), the free form represents only about 1%of the total con-
centration in the systemic circulation (Brodersen et al. 1990;
Fujiwara and Amisaki 2013; Bessonneau et al. 2015b). Salivary
levels of these compounds are very low (nM) and, therefore, diffi-
cult to detectwith untargeted analyses.
Next, we performed pathway enrichment and pathway topol-
ogy analyses to identify the most significant pathways in the sa-
liva exposome. Table 2 summarizes the 14 most significant
metabolic pathways (p≤ 0:05), which prominently includes
amino acid metabolism, TCA cycle, gluconeogenesis, glutathione
metabolism, pantothenate and CoA biosynthesis, and butanoate
metabolism.
Connections between the Saliva Metabolome and Human
Diseases
In order to provide additional biological context for the saliva
metabolome, we evaluated associations between salivary metabo-
lites and MeSH terms using MetDisease. The resulting network
(Figures 3 and 4) indicates that salivary metabolites were associ-
ated with most human diseases (Table 3). For example, substan-
tial evidence from breast cancer epidemiology shows the
influence of hormones at different stages of women’s develop-
ment. A nested case–control study found that premenopausal
concentrations of testosterone were associated with breast cancer
risk (Zeleniuch-Jacquotte et al. 2012). Another case–control
study reported lower salivary testosterone levels in women with
breast cancer, suggesting a protective effect of testosterone
(Dimitrakakis et al. 2010). The carboxylic acid ester phenylace-
tate and its analogs have also been linked to breast neoplasms
(Sawatsri et al. 2001) due to their antiproliferative activities on
human breast cancer cells. Recently, targeted metabolomics of
salivary levels of polyamines such as spermidine has discrimi-
nated breast cancer patients from healthy subjects (Takayama
et al. 2016). Polyamines are essential molecules for normal cell
growth and regulate gene expression by modulating ligand–
receptor interactions, including estradiol binding to estrogens
receptors (Cervelli et al. 2014). Previous studies have attributed
the proliferation of highly invasive breast cancer tumor cells to
the upregulation of polyamine metabolism (Cervelli et al. 2014).
There is also growing evidence that the human gut micro-
biome and its complex interactions with exogenous exposures
Table 1. Blood:saliva concentration ratios and correlations for various classes of small molecules.
Compound Log Pa pKa Blood: saliva ratio (mean) Correlation coefficient (r) Reference
Therapeutic drugs
Clozapine 3.7 15.9 3.6b 0.728 Fisher et al. 2013
Norclozapine 3.2 15.9 3.6b 0.806 Fisher et al. 2013
Quetiapine 2.9 15.1 3.0b 0.843 Fisher et al. 2013
Risperidone 3.4 8.8 2.6b 0.954 Fisher et al. 2013
9-hydroxyrisperidone 2.3 13.7 2.5b 0.640 Fisher et al. 2013
Alprazolam 2.2 18.3 2.3 ND Gjerde et al. 2014
Clonazepam 2.8 11.9 7.1 ND Gjerde et al. 2014
Diazepam 2.6 2.9 27.0 ND Gjerde et al. 2014
Nordiazepam 2.8 12.3 22.0 ND Gjerde et al. 2014
Busulfan −0.9 NA 0.92b 0.980 Rauh et al. 2006
Methylphenidate 1.5 8.9 0.5b ND Seçilir et al. 2013
Mycophenolic acid 2.4 3.6 NRb 0.922 Shen et al. 2009
Voriconazole 1.6 12.7 2.04b 0.943 Vanstraelen et al. 2015
Illicit drugs
Cocaine 1.9 8.8 0.4b ND Moolchan et al. 2000
Benzoylecgonine 1.7 3.1 5b ND Moolchan et al. 2000
Ecgonine methyl ester 0.1 14.6 1b ND Moolchan et al. 2000
Pollutants
Nicotine 0.9 8.9 NRb 0.300 Shin et al. 2002
Cotinine 0.4 4.8 2.3b 0.980 Shin et al. 2002
Perchlorate −0.9 −6.9 0.07c 0.927 Oldi et al. 2009
Endogenous
Cortisol 1.8 12.6 0.87 0.933 Gunnala et al. 2015
7-HydroxyDHEA 1.8 18.2 4.5c 0.975 Hill et al. 2001
Androstenedione 2.9 19.0 NRb 0.781 Juniarto et al. 2011
17-Hydroxyprogesterone 2.9 12.7 NRb 0.964 Juniarto et al. 2011
Testosterone 2.9 19.1 NRc 0.843 Sakaguchi and Hasegawa 2005
Note: ND, not determined.
aFrom in silico prediction using ALOGPS 2.1(http://www.vcclab.org/lab/alogps/).
bPlasma:saliva ratio.
cSerum:saliva ratio.
Figure 1. Source category of salivary metabolites compiled from the saliva
metabolome database (Dame et al. 2015).
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play roles in disease processes (Jiménez et al. 2008; Orešicõ et al.
2008; Nicholson et al. 2012). Of the 14 metabolites of known mi-
crobial origin, 12 were associated with congenital, hereditary,
and neonatal diseases, 11 with nervous system diseases, 10 with
nutritional and metabolic diseases, eight with digestive system
diseases, and seven each with neoplasms and urogenital and preg-
nancy complications.
The above analyses suggest that the saliva metabolome cap-
tures a biologically meaningful fraction of exposures that are
associated with human diseases. Thus, any discriminating
Figure 2. Network of metabolic pathways reconstructed from metabolites detected in human saliva. Gray nodes represent metabolites that had not previously
been detected in saliva but have direct neighbors in metabolic pathways. Edges represent biochemical connections between metabolites.
Table 2.Metabolic pathways represented by the saliva metabolome (metaboanalyst – homosapiens) for pathways having p-values < 0:05 from pathway enrich-
ment analysis. Impact values are derived from pathway topology analysis.
Pathway Total metabolitesa Hitsb p-valuec Impactd
Alanine, aspartate, and glutamate metabolism 24 13 1:4e−4 0.88
beta-Alanine metabolism 28 13 9:8e−4 0.38
Phenylalanine metabolism 45 18 9:9e−4 0.45
Arginine and proline metabolism 77 26 1:7e−3 0.73
Nitrogen metabolism 39 15 4:0e−3 0.22
Citrate cycle (TCA cycle) 20 9 7:7e−3 0.43
Glycolysis or gluconeogenesis 31 12 9:3e−3 0.32
D-Glutamine and D-glutamate metabolism 11 6 9:7e−3 0.64
Glycine, serine, and threonine metabolism 48 16 1:4e−2 0.56
Glutathione metabolism 38 13 2:1e−2 0.35
Pantothenate and CoA biosynthesis 27 10 2:4e−2 0.35
Valine, leucine, and isoleucine biosynthesis 27 10 2:4e−2 0.36
Butanoate metabolism 40 13 3:3e−2 0.21
D-Arginine and D-ornithine metabolism 8 4 5:0e−2 0.50
aTotal number of metabolites involved in the pathway.
bNumber of salivary metabolites involved in the pathway.
cFisher’s exact test was used to measure the association between input metabolites (i.e., salivary metabolites) and pathways. p-Values≤5:0e−2 indicate that associations are less likely
due to random chance.
dImpact represents, on a scale from 0 to 1, the centrality of salivary metabolites in their respective pathways.
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salivary molecules detected by EWAS should be well worth fol-
lowing up in targeted studies to examine sources, causality, dis-
ease mechanisms, and interventions (Rappaport 2012). We
envision that creating exposure terms, similar to MeSH terms
indexed to the peer-reviewed literature, would allow annotation
of metabolites based on their origins and facilitate investigation
of exposure sources and temporality of exposure–disease associa-
tions. For example, Scalbert et al. (2014) performed a compre-
hensive review of metabolites associated with specific food
groups (e.g., red meat, fish, vegetables) from human dietary inter-
ventions and cross-sectional studies. They reported that many
metabolites were significantly correlated (Pearson correlation
r>0:3, p<0:01) with food consumption; e.g., apple consump-
tion was associated with kaempferol, isorhamnetin, m-coumaric
acid and phloretin, carrot consumption with a-carotene, and soy
consumption with daidzein, genistein, isoflavones, and O-desme-
thylangolensin. Likewise, Rappaport et al. (2014) compiled liter-
ature values for 94 environmental chemicals and nutrients that
have been measured in the general population.
Saliva as a Convenient Biospecimen for Longitudinal
Studies
Saliva offers several advantages over traditional biospecimens
archived in population-based studies. As with blood, saliva pro-
vides a snapshot of the internal exposome at the time of collec-
tion. However, whereas blood sampling usually requires a trained
phlebotomist, saliva can be collected by the subjects themselves,
using commercial kits (Shirtcliff et al. 2000; Abraham et al.
2012). This advantage should increase participation rates in
cohort studies, particularly when repeated sampling is desired. In
a recent study of inflammatory bowel disease, Randell et al.
(2016) reported that the participation rate was significantly higher
across 591 participants when they were asked to contribute a
saliva sample (38% participation), compared with blood sample
(23% participation). Similarly, Hansen et al. (2007) found a par-
ticipation rate of 72% when individuals were asked to deliver sa-
liva samples for DNA analysis, compared with 31% for venous
blood samples collected at a medical facility. Another investiga-
tion revealed that the participation rates for collection of saliva
samples and dried blood spots (DBS) were equal at 71.0% for
4,600 women (Sakhi et al. 2015). Although DBS specimens are
also minimally invasive and amenable to self-collection by par-
ticipants, the volume of blood is small (approximately 50lL per
drop) and the analytical matrix consists of both serum and hemo-
lysate, thereby complicating untargeted analysis (Vuckovic
2012). Also, it is unclear whether subjects would be amenable to
repeated collection of DBS, which does involve some discomfort.
Thus, saliva specimens offer an attractive alternative to blood
sampling for investigating individual exposomes with the high
temporal resolution (i.e., repeated measurements) needed to
explore health trajectories. Several studies have found low day-
to-day variability in salivary levels of tightly regulated metabo-
lites such as steroid hormones (Gann et al. 2001; Viardot et al.
2005). For example, Gann et al. (2001) observed that the intra-
class correlation for peak progesterone between two consecutive
menstrual cycles in healthy premenopausal women ranged from
0.72 to 0.76, indicating that cycle-to-cycle variability within
women was smaller than variability across women.
Analytical Considerations
Saliva can easily be collected with a variety of commercial devi-
ces such as Salivette® or Drugwipe®. The most common
approach is to collect saliva with an absorbent pad or swab, from
which saliva is then recovered in the laboratory by centrifugation
(Drummer 2008). Prior to sampling, saliva production can be
stimulated with citric acid and by chewing of gum or sterile pads
Figure 3. Network of PubMed Medical Subject Headings (MeSH) terms reported associated with salivary metabolites. The size of a node and text reflects the
number of metabolites associated with MeSH terms. Edges represent links between MeSH terms.
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(Gröschl et al. 2008; Lund et al. 2011). This approach is often
used to increase the volume of saliva collected and to control the
pH so as to standardize the transfer of acidic and basic molecules.
Unstimulated saliva can be collected passively with a collection
tube or an oral swab (Drummer 2008). Collection devices should
be selected carefully because some media, including cotton and
polypropylene pads, can nonspecifically bind small molecules
(Gallardo and Queiroz 2008; de Almeida et al. 2008; Gröschl
et al. 2008; Higashi 2012). Given that the buccal cavity can be
contaminated by components originating from previous oral
ingestion (Shin et al. 2002), it is useful for subjects to refrain
from eating and drinking for a few hours prior to saliva collec-
tion. Once collected, saliva samples can be easily transported by
mail to the laboratory for analysis. Because a large number of sal-
ivary metabolites such as amino acids, steroids, or fatty acids are
under circadian control (i.e., high diurnal variation) (Dallmann
et al. 2012; Dame et al. 2015), it is important to collect repeated
samples at similar times (e.g., all samples collected during
early morning). Saliva is also an attractive alternative matrix for
pediatric populations, due to the noninvasiveness of the sample
collection. Although several collection devices have been specifi-
cally developed for children 6 mo–6 y old, more studies are
required to address the safety of saliva sampling devices and pro-
cedures in young children.
Several studies have demonstrated that various classes of
compounds, including illicit drugs (Lund et al. 2011), therapeutic
drugs (Mendonza et al. 2006; Moore et al. 2007; Ogawa et al.
2014), pollutants (Bentley et al. 1999; Wang and Lu 2009;
Gherardi et al. 2010), and endogenous steroids (Higashi et al.
2011; Alvi et al. 2013) are stable in saliva for a few days at room
temperature and for at least 1 year when stored at low tempera-
ture (≤ − 20C).
Sample Preparation
The strategy for preparing samples plays an important role in the
quality of metabolomics data. Issues related to the quenching of
metabolism prior to analysis, ion suppression during mass spec-
trometry and metabolite instability can adversely impact the
interpretation of data from untargeted analysis. The most com-
mon techniques for preparing saliva samples for mass spectrome-
try are liquid–liquid extraction (LLE), protein precipitation (PP),
Figure 4. Subnetwork of neoplasm-related PubMed Medical Subject Headings (MeSH) terms reported associated with salivary metabolites. The size of a node
and text reflects the number of metabolites associated with MeSH terms. Edges represent links between MeSH terms.
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and solid-phase extraction (SPE) (Higashi 2012). Although LLE
and PP provide exhaustive extraction of small molecules, such
procedures are labor intensive, difficult to automate, require mul-
tistep sample handling, and are prone to suppression or enhance-
ment of ionization in mass spectrometric analysis. Most of
metabolites in the saliva metabolome database have been
obtained through LLE or PP of saliva samples. These analytical
techniques often used an internal standard in order to correct for
possible loss and/or degradation during sample preparation and
for matrix effects during analysis.
In contrast to LLE and PP, solid-phase microextraction
(SPME) offers a simple, fast, and sensitive technique for prepar-
ing saliva and other biological fluids for metabolomics analysis
(Bojko et al. 2014; Bessonneau et al. 2013, 2015a). In fact, when
coupled to the Concept-96 system (employing 96-well plates),
thin-film SPME (TF-SPME) motivates automation of all precon-
ditioning, extraction, rinsing, and desorption steps (Jiang and
Pawliszyn 2012). For example, preparation for saliva via TF-
SPME can be achieved in less than 2 min per sample and pre-
vents matrix effects and adsorption of macromolecules compared
with LLE (Bessonneau et al. 2015a).
The small size and biocompatibility of SPME materials also
permits in vivo sampling of saliva (Bessonneau et al. 2015a). By
placing the SPME probe in the mouth for a short period of time,
this technique can be used for rapid extraction and stabilization
of metabolites for analysis (Bessonneau et al. 2015b). For exam-
ple, SPME coatings were able to rapidly stabilize highly reactive
metabolites (i.e., eicosanoids) formed in vivo and prevented their
autooxidation during storage (Bessonneau et al. 2015b).
Although promising, in vivo sampling of saliva with SPME is a
new technique that will require substantial validation to address
variability arising from salivary flow rate, pH, sample volume,
and agitation.
The Saliva Adductome
Biotransformation of dietary chemicals and pollutants leads to
the formation of reactive electrophiles, including reactive oxygen
and nitrogen species, aldehydes, oxiranes, and quinones that can
modify DNA, proteins, and lipids and can lead to dysregulation
of homeostasis (Farmer and Davoine 2007; Fritz and Petersen
2013). Because reactive species are unstable, it is difficult to mea-
sure them in their free-circulating form. However, one can detect
adducts formed from reactions between reactive electrophiles and
nucleophilic residues on DNA and proteins. Several targeted
studies have reported correlations between adducts of reactive
electrophiles from endogenous and exogenous sources with DNA
(Sturla 2007,) and prominent blood proteins, that is, hemoglobin
(Hb) and human serum albumin (HSA) [reviewed by Törnqvist
et al. 2002; Rubino et al. 2009].
Both DNA and proteins are also present in saliva, albeit at
lower concentrations than in blood. For example, HSA is found
in saliva at concentrations of about 0.5 mg/mL compared with
35–50 mg/mL in serum (Wang et al. 2012; Shaila et al. 2013;
Metgud and Patel 2014; Nam et al. 2015); whereas Hb is present
at a 50,000-fold lower concentration in saliva (3:3lg=mL) com-
pared with blood (150 mg/mL) (Nomura et al. 2012). For DNA,
mean salivary levels (12lg=mL) are 2-fold lower than those in
blood (26lg=mL) (Abraham et al. 2012). Although the analysis
of salivary adducts is still in its infancy, targeted studies have
reported adducts of salivary DNA with electrophiles from smok-
ing and dietary sources (Bessette et al. 2010; Chen and Lee 2014;
Chen and Lin 2014), and of HSA adducts in nasal lavage fluid
from workers exposed to reactive electrophiles (Kristiansson
et al. 2004; Jeppsson et al. 2009).
Untargeted analysis of adducts of DNA, HAS, and Hb has
motivated adductomics for untargeted characterization of expo-
sures to reactive electrophiles (Rappaport et al. 2012). That is, an
adductome represents the totality of adducts generated from reac-
tions between reactive electrophiles and a particular nucleophilic
locus on one of these molecules. By characterizing a complete
adductome, it is possible to map systemic exposures that occurred
over the in vivo residence time of the nucleophile, which can
range from hours to months. Particular attention has been paid to
mass spectrometric characterization of DNA adductomes in
human tissue samples (reviewed by Balbo et al. 2014) and the
blood proteins, HSA (Li et al. 2011; Grigoryan et al. 2016) and
Hb (Carlsson et al. 2014).
Here, we posit that salivary HSA and Hb residence times
would be similar to those in blood (i.e., 30 days for HSA and
60 days for Hb), which are much longer than those for DNA (a
few days). Consequently, by performing untargeted mass spec-
trometry of HSA and Hb adducts in saliva samples, it should
be possible to characterize systemic exposures to reactive elec-
trophiles during 1–2 mo prior to specimen collection. With
repeated saliva sampling every few years, one can construct an
individual exposure history of relevance to a person’s health
trajectory.
Conclusions
Saliva contains a rich set of molecular information for circulating
chemicals that can be interrogated via EWAS, with metabolomics
and adductomics, to discover exposure–risk factors for chronic
diseases. Although the number of metabolites detected in saliva
is smaller than that in blood, we can anticipate that analytical
improvements will uncover many additional salivary metabolites,
present at low concentrations.
Given the simplicity and noninvasiveness of specimen collec-
tion, saliva offers a practical alternative to blood for longitudinal
measurements of individual’s exposomes. Several studies have
shown that participants are more willing to donate saliva speci-
mens than venous blood, and saliva can be collected by the sub-
jects themselves. This would eventually improve participation
rates in cohort studies and, therefore, generate larger sets of
biospecimens.
Data-driven studies that utilize repeated omic measurements
from individuals at different stages of life should reduce exposure
measurement errors and thereby increase power to discover
unknown causes of chronic diseases. Given the ease of collection,
saliva could well be the specimen of choice for obtaining
repeated samples to profile small molecules, DNA, and proteins.
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